Table 6 Cytotoxicity of compounds 15, 16, 17, 18, 19, 20 and Doxorubicin against breast carcinoma cell line MCF-7

500

8.76

5.28

7.95

6.17

5.21

8.25

1.51

250

13.81

13.96

21.34

13.92

11.36

16.37

2.36

125

26.92

21.47

30.67

21.40

20.84

28.72

3.21

62.5

37.24

32.68

38.72

28.57

27.30

41.89

5.07

31.25

48.17

36.43

51.90

36.71

35.26

49.78

6.93

15.6

60.95

42.90

64.18

48.86

39.48

80.93

15.46

7.8

76.43

51.72

72.37

69.52

46.29

92.34

19.89

3.9

89.71

69.37

88.45

81.94

54.68

97.28

24.98

2

97.02

83.19

92.32

90.68

69.31

100

31.69

1

100

92.48

97.45

96.25

80.47

100

40.17

0

100

100

100

100

100

100

100